Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Clinical and Vaccine Immunology : CVI|December 14, 2007
Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassayDavid Zhuang, Chadi Hage, Magdia De Jesus, et al.
Journal of Cardiothoracic and Vascular Anesthesia|November 16, 2021
Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO SupportRussell Trigonis, Nikki Smith, Shelley Porter, et al.
Oncology Research|February 6, 2004
Pleural mesothelial cell (PMC) defense mechanisms against malignancyNajmunnisa Nasreen, Kamal A Mohammed, Kerry Sanders, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
IJID Regions|March 19, 2026
Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical reviewChadi Hage Chehade, Bassem Habr, Carine Harmouche, et al.
CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate CarcinomaEmre Dal, Ayana Srivastava, Beverly Chigarira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate CancerChadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
Clinical Genitourinary Cancer|December 25, 2024
Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial CarcinomaNicolas Sayegh, Yeonjung Jo, Georges Gebrael, et al.
Pageof 6